← Back to all trials
Completed
NCT05773066
A Study of Belotero® Intense Lidocaine for Lip Augmentation
Conditions: Lip Augmentation
Sex: All
Ages: 21 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 220
Sponsor: Merz North America, Inc.
Location: Merz Investigation Site #0010463 Redondo Beach California
Summary
The purpose of this study is to demonstrate the safety and effectiveness of Belotero Intense Lidocaine (BIL) for lip augmentation in subjects with upper and/or lower lip deficit.
Eligibility Criteria
Inclusion Criteria:
* Desires lip augmentation to correct volume and has very thin to medium upper and/or lower lip deficit
Exclusion Criteria:
* Any previous surgery, including plastic surgery or permanent implant or graft in the lower third part of the face
* Any previous treatment with fat injections or permanent and/or semi-permanent dermal fillers in the face
* Any treatment with porcine-based collagen fillers or with Juvéderm® Voluma XC, Restylane® Lyft Lidocaine, Calcium hydroxyapatite (CaHA) within the past 24 months and/or other dermal fillers within the past 12 months in the lips, in the lower third part of the face, and/or the nose
* Any previous treatment with dermal therapies within the past 3 months in the lower third part of the face
* Has undergone oral surgery in the past 30 days
* Lip volume deficit due to medical conditions
* Known history of allergic/anaphylactic reactions/hypersensitivity to lidocaine or any of the device components
Source: ClinicalTrials.gov (NCT05773066). StuddyBuddy aggregates publicly available trial information.